Hubei Biocause Heilen Pharmaceutical Co., Ltd.

SZSE:301211 Stock Report

Market Cap: CN¥5.5b

Hubei Biocause Heilen Pharmaceutical Dividends and Buybacks

Dividend criteria checks 2/6

Hubei Biocause Heilen Pharmaceutical is a dividend paying company with a current yield of 2.5%.

Key information

2.5%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.480
Payout ratio130%

Recent dividend and buyback updates

Hubei Biocause Heilen Pharmaceutical (SZSE:301211) Will Pay A Larger Dividend Than Last Year At CN¥0.48

May 22
Hubei Biocause Heilen Pharmaceutical (SZSE:301211) Will Pay A Larger Dividend Than Last Year At CN¥0.48

Recent updates

Hubei Biocause Heilen Pharmaceutical's (SZSE:301211) Shareholders Have More To Worry About Than Lackluster Earnings

Nov 04
Hubei Biocause Heilen Pharmaceutical's (SZSE:301211) Shareholders Have More To Worry About Than Lackluster Earnings

Earnings Not Telling The Story For Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SZSE:301211) After Shares Rise 43%

Oct 30
Earnings Not Telling The Story For Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SZSE:301211) After Shares Rise 43%

Earnings Not Telling The Story For Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SZSE:301211)

Aug 07
Earnings Not Telling The Story For Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SZSE:301211)

Hubei Biocause Heilen Pharmaceutical (SZSE:301211) Will Pay A Larger Dividend Than Last Year At CN¥0.48

May 22
Hubei Biocause Heilen Pharmaceutical (SZSE:301211) Will Pay A Larger Dividend Than Last Year At CN¥0.48

Hubei Biocause Heilen Pharmaceutical's (SZSE:301211) Promising Earnings May Rest On Soft Foundations

Apr 29
Hubei Biocause Heilen Pharmaceutical's (SZSE:301211) Promising Earnings May Rest On Soft Foundations

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, 301211 has been paying a dividend for less than 10 years.

Growing Dividend: 301211's dividend payments have increased, but the company has only paid a dividend for 2 years.


Dividend Yield vs Market

Hubei Biocause Heilen Pharmaceutical Dividend Yield vs Market
How does 301211 dividend yield compare to the market?
SegmentDividend Yield
Company (301211)2.5%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.2%
Industry Average (Pharmaceuticals)1.7%
Analyst forecast (301211) (up to 3 years)n/a

Notable Dividend: 301211's dividend (2.5%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 301211's dividend (2.5%) is in the top 25% of dividend payers in the CN market (2.17%)


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (129.8%), 301211's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 301211 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies